M. Hasmann

Molecular Biology · 2003–2009

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Hasmann trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Evan

Who trusts M. Hasmann overall

  1. M. Fulco
  2. M. V. Vander Heiden
  3. C. Cantó
  4. Yana Cen
  5. K. Mills
  6. Jun Yoshino
  7. J. Spratlin

Papers from M. Hasmann's perspective

Ordered by how strongly the researchers M. Hasmann trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Proliferation, cell cycle and apoptosis in cancer (Nature)
  2. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. (Experimental Cell Research)
  3. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets (Nature Medicine)
  4. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death (Nature)
  5. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. (Cancer Cell)
  6. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. (Cancer Cell)
  7. The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells (Cancer Research)
  8. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
  9. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
  10. Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells. (Cancer Research)

Their papers